Background: The present study was conducted to evaluate the levels of interleukin (IL) -17 in gingival crevicular fluid (GCF) and placental tissue samples of pregnant females as a possible marker in determining whether or not an association exists between chronic periodontitis and preterm labor. Methods: This case-control study included a random sample of 40 female patients, aged 18 to 35 years, who were assigned to one of the following four groups (10 subjects each): group 1 included patients who underwent spontaneous preterm birth (PB) and were diagnosed with chronic periodontitis upon clinical examination (preterm/periodontitis); group 2 included patients who underwent spontaneous PB and who had a healthy periodontium upon clinical examination (preterm/healthy periodontium); group 3 included patients who underwent spontaneous normal term birth and were diagnosed with chronic periodontitis upon clinical examination (term/periodontitis); and group 4 included patients who underwent spontaneous normal term birth and who had a healthy periodontium upon clinical examination (term/healthy periodontium). GCF and placental tissue samples were obtained from each patient and IL-17 levels were measured using enzyme-linked immunosorbent assay (ELISA). Results: GCF levels of IL-17 were significantly higher (P=0.010) in patients with chronic periodontitis compared to those with a healthy periodontium. No significant differences were observed in IL-17 levels in placental tissue samples of all study groups. Conclusion: An association between chronic periodontitis and preterm labor could not be established based on IL-17 levels measured in the present study.
Introduction
Pregnancy is normally a healthy physiological process that sometimes has adverse outcomes including low birth weight (LBW) (<2500 grams) and preterm birth (PB) (<37 weeks). PB is now the second most common cause of death worldwide in children younger than five years after pneumonia. 1 As normal pregnancy progresses, amniotic fluid levels of prostaglandin E2 (PGE2) and inflammatory cytokines, such as tumor necrosis factor-alpha (TNF-α) and interleukin-1 beta (IL-1β) rise steadily until a critical threshold is reached to induce rupture of the amniotic sac membranes, uterine contraction, cervical dilation, and finally delivery. 2 Thus, normal parturition is controlled by inflammatory signaling and this process represents a triggering mechanism that can be modified by external stimuli including infection and inflammatory stressors. 3 Two major pathways have been proposed to trigger an inflammatory/immune response and/or suppression of local growth factors in the fetal-placental unit. The direct pathway suggests that oral microorganisms www.perioj.com and/or their components reach the fetalplacental unit via hematogenous dissemination from the oral cavity, or via the genitourinary tract. The indirect pathway suggests that inflammatory mediators locally produced in periodontal tissues, for example PGE2 and TNF-α, circulate and impact the fetal-placental unit, or inflammatory mediators and/or microbial components circulate to the liver, enhancing cytokine production (e.g. IL-6) and acute phase response (e.g. C-reactive protein), which then impact the fetal-placental unit. 1, 3 Numerous studies have associated an increase in the levels of local and systemic markers of inflammation with adverse pregnancy outcomes (APOs). Elevated levels of IL-1β, IL-6, TNF-α, PGE2, fibronectin, and α-fetoprotein in the amniotic fluid have been associated with PB. 4 Increased maternal serum levels of pro-inflammatory cytokines, such as IL-1, IL-6, IL-8, and TNF-α, have also been reported to be associated with prematurity or LBW. 5 Moreover, C-reactive protein (CRP), which is an acute phase reactant synthesized by the liver in response to proinflammatory cytokines, and hence a marker of systemic inflammation, was also reported to be associated with PB. 6 Periodontal diseases are a group of infectious/inflammatory diseases involving Gram negative, anaerobic, and microaerophilic bacteria that colonize the subgingival area and cause local and systemic elevations of proinflammatory prostaglandins and cytokines, resulting in tissue destruction. 3, 7 During pregnancy, due to physiological hormonal changes, there is a systematic inclination to periodontal disease. There is a global rise in anaerobic Gram-negative agents in particular, such as Fusobacterium nucleatum, Treponema denticola, Tannerella forsythia, and Campylobacter rectus. 8 Moreover, especially during pregnancy, the hormonal changes due to elevated levels of estrogens and progesterone increase vascular permeability in the gingival tissues and, as a consequence, bacteria and/or their products can more readily diffuse through the tissues. Evidence indicates that periodontal pathogens/byproducts may reach the fetalplacental unit. 3 In this context, Madianos et al. found that maternal serum immunoglobulin G (IgG) specific to oral organisms was associated with decreased PB and increased birth weight. In the presence of maternal oral organisms, the lack of a protective maternal IgG response could increase fetal exposure which may in turn contribute to a fetal immune response that could lead to PB. 9 Porphyromonas gingivalis and Aggregatibacter actinomycetemcomitans, both established periodontal pathogens, have also been found in the placenta of women with PB or pre-eclampsia. 10 In periodontally affected patients, there is an increase in the production of proinflammatory cytokines and mediators from periodontal tissues. Once released, they may diffuse in the gingival crevicular fluid (GCF) or enter the blood circulation and reach the placenta-fetus interface. The production of prostaglandins could be stimulated by IL-1, IL-6, and TNF-α in the chorion, and in conjunction with the maternally derived PGE2 generated at the gingival level and released in the circulation, may exacerbate cervical ripening and uterine contraction leading to an increased risk for PB. 3 Interleukin (IL) -17 is an important proinflammatory cytokine which induces the expression of many mediators of inflammation and is critical to host defense. It has been reported that amniotic IL-17 levels were significantly higher in cases of preterm delivery compared to term delivery. In humans, IL-17 was identified first in CD4 + T cells followed by CD8 + T cells, γδ T cells, and monocytes. This cytokine has been linked to various chronic inflammatory conditions including: periodontitis, rheumatoid arthritis, inflammatory bowel disease, multiple sclerosis, and cancer. IL-17 binds to its receptor, IL-17 receptor A (IL-17 RA), and signals are transmitted through nuclear factor kappa-lightchain-enhancer of activated B cells (NF-kB) and the mitogen-activated protein kinase (MAPK). 11 IL-17 has been reported to up-regulate IL-1β, TNF-α, and the tissue destructive matrix metalloproteinases (MMP) -1 and 3 in periodontal disease. It also induces the production IL-6 and IL-8 from gingival fibroblasts. 12 An increase has been reported in the amount of IL-17 in GCF samples and in the culture supernatants of gingival cells in periodontal disease. 13 Although a large number of epidemiological and intervention studies demonstrate a positive association between periodontal disease and APOs, the results are not always consistent. 14 Therefore, the present study will be conducted to investigate the correlation between periodontal disease and PB by measuring the levels of IL-17, a highly sensitive novel inflammatory marker, in both GCF and placental tissues samples. 15 2) spontaneous normal term birth at ≥37 weeks of gestation without any obstetrical or medical complications; 3) spontaneous PB at <37 weeks of gestation after uterine contraction or rupture of membranes. 16 Exclusion criteria included: 1) history of medications that may affect the study outcome, such as: current use of systemic corticosteroids or antibiotics for at least one month; 2) genital and urinary tract infections; 3) existing hypertension and diabetes mellitus before pregnancy, autoimmune disease, asthma, and chronic renal disease; 4) multiple pregnancies, cervical cerclage, abnormal placentation, past history of preterm delivery, or antepartum hemorrhage; and 5) low or high maternal body mass index. All procedures performed in the present study were in accordance with the protocol approved by the Ain Shams University Research Ethics Committee. The nature and aim of the study was explained to each individual patient, and both verbal and written consents were obtained from all of the participants. All of the obtained information was treated with confidentiality. The study protocol was registered and identified as NCT03171675 at the U.S. National Institutes of Health Clinical Trials Registry. 
Subjects and Methods

I -Patient Selection
II -Clinical Evaluation and Patient Grouping
Patients who met the eligibility criteria received full-mouth periodontal examinations at the maternity ward within 24 hours postpartum. Full mouth baseline periodontal parameters were recorded for each patient, which included: plaque index (PI), 17 gingival index (GI), 18 probing depth (PD), 19 and clinical attachment level (CAL). 19 All parameters were examined using a University of Michigan ʿOʾ Probe with William's markings. Patients with ≥ 30 % full arch probing depth of >3 mm, who demonstrated periodontal clinical attachment loss, and who had a gingival index of 1-3, were diagnosed with chronic periodontitis. 20 Subjects with a probing depth of ≤ 3 mm, who lacked periodontal clinical attachment loss, and who had a gingival index of 0-0.5, were deemed to have a healthy periodontium.
All participants were assigned to one of the following four groups (10 patients each): group 1 included patients who underwent spontaneous PB and were diagnosed with chronic periodontitis upon clinical examination (preterm/periodontitis); group 2 included patients who underwent spontaneous PB and who had a healthy periodontium upon clinical examination (preterm/healthy periodontium); group 3 included patients who underwent spontaneous normal term birth and were diagnosed with chronic periodontitis upon clinical examination (term/periodontitis); and group 4 included patients who underwent spontaneous normal term birth and who had a healthy periodontium upon clinical examination (term/healthy periodontium). 
III -Sample Collection
GCF and placental tissue samples were obtained from each subject. Sterile absorbing paper strips d were used to obtain GCF samples. For patients diagnosed with chronic periodontitis, a single sample was taken from the site possessing the highest PD along with the most clinical attachment loss; while for patients exhibiting a healthy periodontium, a random site was used to obtain the sample. Cotton gauze sponges were used to isolate the teeth being sampled and the absorbing paper strips were d Periopaper™ , Oraflow, Smithtown, NY, USA 11787 gently placed into the gingival sulcus of the collection site until mild resistance was encountered, and were left in place for approximately 15 seconds. 21 Each sample was placed into a cooled Eppendorf tube and stored at -80 C for future use. Using a scalpel, a small piece of villous placental tissue (approximately 1 cm 3 ) was dissected free of the maternal decidua from the placental bed after delivery. Each sample was placed into a cooled Eppendorf tube and stored at -80 C for future use. Enzyme-linked immunosorbent assay (ELISA) e was used to assess the level of IL-17 in each sample. The unopened kit was stored at approximately 5 C. This immunoassay is a 4.5 hour solid phase ELISA built to measure human IL-17 in cell culture supernates, serum, andplasma. It is comprised of E. coli-expressed human IL-17 and antibodies raised against the recombinant factor.
The duplicate readings for each standard, control, and sample were averaged, and the average zero standard optical density (O.D.) was subtracted. A standard curve was created by reducing the data using computer software capable of producing log/log curve-fit.
IV -Statistical Analysis
The primary objective of the present study was to evaluate the levels of IL-17 in GCF and placental tissue samples of both healthy and periodontally affected females who underwent PB. The secondary objective was to correlate clinical parameters with IL-17 levels in GCF and placental tissue samples. A power analysis was designed to have adequate power to apply a 2-sided statistical test of the research hypothesis (Null hypothesis) that there was no difference between the two groups (chronic periodontitis and healthy periodontium 
Results
No statistically significant differences were recorded in the periodontal parameters of the preterm and term/healthy periodontium groups. Similarly, the preterm/periodontitis group demonstrated insignificant differences compared to the term/periodontitis group, at p≤0.05, regarding the mean GI, PD, and CAL. The preterm/periodontitis group had a significantly higher mean PI compared to term/periodontitis study group (Table 2) .
Regarding the mean IL-17 levels in the GCF samples, a statistically significant difference was found between the term/periodontitis and term/healthy periodontium groups, with values at 55.92±15.54 pg/ml and 42.94±8.25 pg/ml respectively (p<0.05). A statistically significant difference between the preterm/healthy periodontium and the term/periodontitis groups (p<0.05) was also recorded, while the preterm/periodontitis group demonstrated an insignificant difference when compared to the rest of the study groups at p=0.05 (Table 3) . The chronic periodontitis and the healthy periodontium study groups demonstrated a statistically significant difference regarding the mean IL-17 levels in the GCF samples (p=0.01) (Table 4) . However, no statistically significant difference was recorded for the preterm delivery and the term delivery groups (p=0.123) ( Table 5) .
Regarding the mean IL-17 levels in the placental tissue samples, no statistically significant differences were demonstrated between all study groups at p=0.05. The highest level was found in the preterm/periodontitis study group, followed by the preterm/healthy periodontium study group, while the term/periodontitis study group demonstrated the lowest level (Table 3) . No statistically significant difference was demonstrated between the chronic periodontitis and the healthy periodontium study groups regarding the mean www.perioj.com IL-17 levels in the placental tissue samples (p=0.550) ( Table 6 . Spearman ranked correlation coefficients between mean IL-17 levels in GCF and placental tissue samples, gestation duration, and clinical periodontal parameters of all groups r = Correlation coefficient; p = Probability level; GD = Gestation duration; PT = Placental tissue; * Correlation is significant at the 0.01 level.
Discussion
Serious health problems are associated with preterm low birth weight (PLBW) infants including, neurodevelopment disturbances, ear infections, respiratory infections, asthma, and death. Premature birth causes 10% of neonatal mortality worldwide. 22 Despite immense medical advances, the rate of PB has not declined in the United States over the past several decades. The rate actually rose to more than 12% of all births in the year 2003. Thus, identifying risk factors for PB, especially those that can be controlled or treated, would certainly have far-reaching and long-lasting effects. 23 Although it has been asserted that periodontopathogens from oral infection can disseminate to distant body sites and thus result in the delivery of PLBW infants, results have been inconclusive. 24, 25, 26, 27 Some studies have demonstrated positive correlations, while others have not. 28, 29, 30, 31, 32, 33, 34, 35 Although these results seem contradictory, factors such as race, geographical location, and socioeconomic standards have not been adequately adjusted for. Consequently, studies conducted in the United States and Europe differ from those conducted in Latin America or Africa, mainly due to a lack of adjustment for socio-economic factors, such as accessibility to adequate and affordable health care. 23 In the present study, IL-17 was chosen as a possible marker for preterm labor in patients with chronic periodontitis for several reasons. Since IL-17 has been found to up-regulate IL-1β Cellular and humoral responses in both healthy individuals and those with periodontal disease have been detected through GCF analysis. 21 In the present study, GCF was used to measure IL-17 levels associated with periodontitis since it is considered an excellent undispersed media for evaluating the released IL-17. Brill and Krasse inserted filter paper into the gingival sulci of dogs that had previously been given intramuscular fluorescein injections. The fluorescent material was absorbed on the paper strips within 3 minutes. This demonstrated that fluid passed from the bloodstream through the tissues, and subsequently into the gingival sulcus. In later studies, Brill verified the presence of GCF in humans and considered it a "transudate." 36, 37, 38, 39 Sterile gingival fluid collection absorbing paper strips were used in the present study to obtain GCF samples due to their simplicity, convenience, and ease of use. The Brill technique, which involves inserting the absorbing paper strip into the sulcus until resistance is encountered, was used to obtain the GCF samples. This technique was chosen because it irritates the sulcular epithelium to some degree, subsequently leading to the flow of fluid. 21 In the present study, placental tissue samples were obtained from the subjects rather than amniotic fluid samples, due to the invasiveness of amniocentesis. Gram-negative periodontal bacteria and/or their virulence factors (e.g. endotoxins) have been shown to reach the systemic circulation, producing a lowgrade bacteremia. This is especially true during pregnancy, during which elevated levels of estrogen and progesterone increase vascular permeability in the gingival tissues, and consequently, diffusion of bacteria and/or their products occurs more readily. Immunological data has indicated that periodontal pathogens/byproducts may reach the fetalplacental unit. Upon exposure of the mother to bacterial pathogens, an attempt will be made by the host's immune response to contain and resolve the infection. If this is unsuccessful, then bacterial-specific antibodies will be produced by the more efficient adaptive immune response. 3 Although Keelan et al. reported increased cytokine levels in the gestational membranes of both term and preterm labor patients, signifying an inflammatory process, this process was not evident in the villous placenta. Thus, cytokine concentrations within placental tissues were not affected by labor. 16 His study however lacked an exposure factor, as is the case in the present study, where two of the study groups were diagnosed with chronic periodontitis, a disease which has been associated with increased IL-17 levels. 12, 13 It has been hypothesized that PB may be precipitated by cytokines produced by the infected periodontium, which may reach the systemic circulation and subsequently target the placenta and fetus. 40 Our results however, suggest that this is not the case given that the IL-17 levels in GCF fluid did in fact increase in chronic periodontitis compared to our healthy periodontium groups, whereas this increase was not demonstrated in the IL-17 levels in placental tissue samples.
The present study demonstrated a statistically significant difference between the term/periodontitis and the term/healthy periodontium groups regarding the mean IL-17 levels in the GCF samples, with higher levels having been detected in the term/periodontitis study group. A statistically significant difference was also found (p=0.010) between mean IL-17 levels in the GCF samples of the chronic periodontitis and healthy periodontium study groups, with levels being considerably higher in the chronic periodontitis study groups. These findings conform to those of Beklen et al. and Vernal et al., both of whom reported elevated IL-17 levels in periodontitis. 12, 13 However, no statistically significant differences were found (p=0.123) regarding the mean IL-17 levels in the GCF samples of both preterm and term delivery groups. Furthermore, the results demonstrated no statistically significant differences, at p=0.05, between all study groups regarding the mean level of IL-17 in placental tissue samples. These findings are consistent with those of Wood et al., Bassani et al., Abati et al., Souccar et al., and other authors who found no association between periodontitis and preterm labor. 32, 33, 34, 35 Conclusively, we could not establish an association between chronic periodontitis and preterm labor based on the measured IL-17 levels in GCF and placental tissue samples in the present study. Despite limitations, including a small sample size and lack of intervention, this is a pioneer case-control study that can be added to the database of evidence-based research in this particular field of periodontology.
